Monteiro L, Barbieri C, Warnakulasuriya S, Martins M, Salazar F, Pacheco JJ, Vescovi P, Meleti M. Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study. Med Oral Patol Oral Cir Bucal. 2017 Sep 1;22 (5):e520-6.

 

 

doi:10.4317/medoral.21645

http://dx.doi.org/doi:10.4317/medoral.21645

 

 

1. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575-80.
https://doi.org/10.1111/j.1600-0714.2007.00582.x

 

2. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770-80.
https://doi.org/10.1016/S1368-8375(03)00102-7

 

3. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol. 1997;33:291-301.
https://doi.org/10.1016/S1368-8375(97)00002-X

 

4. van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal. 2014;19:e386-90.
https://doi.org/10.4317/medoral.20205

 

5. Maserejian NN, Joshipura KJ, Rosner BA, Giovannucci E, Zavras AI. Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev. 2006;15:774-81.
https://doi.org/10.1158/1055-9965.EPI-05-0842

 

6. Bagan JV, Jimenez Y, Murillo J, Gavalda C, Poveda R, Scully C, et al. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection. J Oral Maxillofac Surg. 2007;65:46-9.
https://doi.org/10.1016/j.joms.2005.12.066

 

7. Arduino PG, Bagan J, El-Naggar AK, Carrozzo M. Urban legends series: oral leukoplakia. Oral Dis. 2013;19:642-59.
https://doi.org/10.1111/odi.12065

 

8. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 2009;31:1600-9.
https://doi.org/10.1002/hed.21131

 

9. Lodi G, Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med. 2008;37:63-9.
https://doi.org/10.1111/j.1600-0714.2007.00575.x

 

10. Ishii J, Fujita K, Komori T. Laser surgery as a treatment for oral leukoplakia. Oral Oncol. 2003;39:759-69.
https://doi.org/10.1016/S1368-8375(03)00043-5

 

11. Lim B, Smith A, Chandu A. Treatment of oral leukoplakia with carbon dioxide and potassium-titanyl-phosphate lasers: a comparison. J Oral Maxillofac Surg. 2010;68:597-601.
https://doi.org/10.1016/j.joms.2009.03.028

 

12. van der Hem PS, Nauta JM, van der Wal JE, Roodenburg JL. The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up. Oral Oncol. 2005;41:31-7.
https://doi.org/10.1016/j.oraloncology.2004.06.010

 

13. Tewari M, Rai P, Singh GB, Kumar M, Shukla HS. Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity. J Surg Oncol. 2007;95:281-5.
https://doi.org/10.1002/jso.20677

 

14. Brouns ER, Baart JA, Karagozoglu KH, Aartman IH, Bloemena E, van der Waal I. Treatment results of CO2 laser vaporisation in a cohort of 35 patients with oral leukoplakia. Oral Dis. 2013;19:212-6.
https://doi.org/10.1111/odi.12007

 

15. Chandu A, Smith AC. The use of CO2 laser in the treatment of oral white patches: outcomes and factors affecting recurrence. Int J Oral Maxillofac Surg. 2005;34:396-400.
https://doi.org/10.1016/j.ijom.2004.10.003

 

16. Thomson PJ, Wylie J. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management. Int J Oral Maxillofac Surg. 2002;31:145-53.
https://doi.org/10.1054/ijom.2001.0189

 

17. Jerjes W, Upile T, Hamdoon Z, Al-Khawalde M, Morcos M, Mosse CA, et al. CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation. Lasers Med Sci. 2012;27:169-79.
https://doi.org/10.1007/s10103-011-0916-z

 

18. Gooris PJ, Roodenburg JL, Vermey A, Nauta JM. Carbon dioxide laser evaporation of leukoplakia of the lower lip: a retrospective evaluation. Oral Oncol. 1999;35:490-5.
https://doi.org/10.1016/S1368-8375(99)00022-6

 

19. Hamadah O, Thomson PJ. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study. Lasers Surg Med. 2009;41:17-25.
https://doi.org/10.1002/lsm.20733

 

20. Yang SW, Tsai CN, Lee YS, Chen TA. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the factors affecting recurrence. J Oral Maxillofac Surg. 2011;69:e78-87.
https://doi.org/10.1016/j.joms.2010.11.029

 

21. Chiesa F, Boracchi P, Tradati N, Rossi N, Costa L, Giardini R, et al. Risk of preneoplastic and neoplastic events in operated oral leukoplakias. Oral Oncol. 1993;29B(1):23-8.
https://doi.org/10.1016/0964-1955(93)90006-Z

 

22. Schoelch ML, Sekandari N, Regezi JA, Silverman S Jr. Laser management of oral leukoplakias: a follow-up study of 70 patients. Laryngoscope. 1999;109:949-53.
https://doi.org/10.1097/00005537-199906000-00021

 

23. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med. 2011;40:677-83.
https://doi.org/10.1111/j.1600-0714.2011.01054.x

 

24. Yang SW, Wu CJ, Lee YS, Chen TA, Tsai CN. Postoperative recurrence as an associated factor of malignant transformation of oral dysplastic leukoplakia. ORL J Otorhinolaryngol Relat Spec. 2010;72:280-90.
https://doi.org/10.1159/000318874

 

25. Lopez-Jornet P, Camacho-Alonso F. Comparison of pain and swelling after removal of oral leukoplakia with CO(2) laser and cold knife: a randomized clinical trial. Med Oral Patol Oral Cir Bucal. 2013;18:e38-44.
https://doi.org/10.4317/medoral.17960

 

26. Del Corso G, Gissi DB, Tarsitano A, Costabile E, Marchetti C, Montebugnoli L, et al. Laser evaporation versus laser excision of oral leukoplakia: A retrospective study with long-term follow-up. J Craniomaxillofac Surg. 2015;43:763-8.
https://doi.org/10.1016/j.jcms.2015.04.009

 

27. Seoane J, Gonzalez-Mosquera A, Lopez-Nino J, Garcia-Caballero L, Aliste C, Seoane-Romero JM, et al. Er,Cr:YSGG laser therapy for oral leukoplakia minimizes thermal artifacts on surgical margins: a pilot study. Lasers Med Sci. 2013;28:1591-7.
https://doi.org/10.1007/s10103-013-1266-9

 

28. Vescovi P, Corcione L, Meleti M, Merigo E, Fornaini C, Manfredi M, et al. Nd:YAG laser versus traditional scalpel. A preliminary histological analysis of specimens from the human oral mucosa. Lasers Med Sci. 2010;25:685-91.
https://doi.org/10.1007/s10103-010-0770-4

 

29. Kuribayashi Y, Tsushima F, Sato M, Morita K, Omura K. Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy. J Oral Pathol Med. 2012;41:682-8.
https://doi.org/10.1111/j.1600-0714.2012.01167.x

 

30. Vescovi P, Manfredi M, Merigo E, Fornaini C, Rocca JP, Nammour S, et al. Quantic molecular resonance scalpel and its potential applications in oral surgery. Br J Oral Maxillofac Surg. 2008;46:355-7.
https://doi.org/10.1016/j.bjoms.2007.09.014